Structure-guided approach to modify the substrate specificity of the protein human deglycase-1 (hDJ-1)

Glycation is a non-enzymatic reaction wherein sugars or dicarbonyls such as methylglyoxal (MGO) and glyoxal (GO) react with proteins, leading to protein inactivation. The hydrolysing enzyme human deglycase-1 (hDJ-1) is reported to decrease glycative stress by deglycating the modified proteins, specifically at cysteine, lysine, and arginine sites. This specificity of hDJ-1 is thought to be regulated by its active site cysteine residue (Cys106). Structural analysis of hDJ-1 by molecular docking and simulation studies, however, indicates a possible role of glutamate (Glu18) in determining its substrate specificity. To elucidate this, Glu18 present at the catalytic site of hDJ-1 was modified to aspartate (Asp18) by SDM, and the resultant mutant was termed mutant DJ-1 (mDJ-1). Both hDJ-1 and mDJ-1 were heterologously expressed in Escherichia coli BL21 (DE3) strain and purified to ho-mogeneity. The hDJ-1 showed kcat values of 1.45 x 103 s- 1, 3.6 x 102 s- 1, and 3.1 x 102 s- 1, and Km values 0.181 mM, 18.18 mM, and 12.5 mM for N-acetylcysteine (NacCys), N-acetyllysine (NacLys), and N-acetylargi-nine (NacArg), respectively. The mDJ-1 showed altered kcat values (8 x 102 s- 1, 3.8 x 102 s- 1, 4.9 x 102 s- 1) and Km values of 0.14 mM, 6.25 mM, 5.88 mM for NacCys, NacLys and NacArg, respectively. A single amino acid change (Glu18 to Asp18) improved the substrate specificity of mDJ-1 toward NacLys and NacArg. Understanding hDJ-1's structure and enhanced functionality will facilitate further exploration of its therapeutic potential for the treatment of glycation-induced diabetic complications.

Automated summary

Glycation is a reaction that leads to protein inactivation, but the enzyme hDJ-1 can reverse this process. The specificity of hDJ-1 is regulated by its active site residue Cys106, and structural analysis suggests a potential role of Glu18. Modifying Glu18 to Asp18 improves the substrate specificity of hDJ-1.